Search research articles
Contact Us
Filters
Showing results (1-10 of 190) with videos related to
Page
of 19
Sort By:
Endocrine Journal
|
April 14, 2022
Glucokinase as a therapeutic target based on findings from the analysis of mouse models
Akinobu Nakamura
International Journal of Molecular Sciences
|
May 14, 2022
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function
Akinobu Nakamura
Journal of Diabetes Investigation
|
August 28, 2021
Impaired insulin secretion and related factors in East Asian individuals
Akinobu Nakamura, Yasuo Terauchi
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2017
Ratiometric fluorescence imaging of nuclear pH in living cells using Hoechst-tagged fluorescein
Akinobu Nakamura, Shinya Tsukiji
International Journal of Molecular Sciences
|
November 29, 2013
Lessons from mouse models of high-fat diet-induced NAFLD
Akinobu Nakamura, Yasuo Terauchi
Endocrine Journal
|
September 14, 2012
Factors associated with the glucose-lowering effect of vildagliptin identified from the results of the oral glucose tolerance test in Japanese patients with type 2 diabetes
Akinobu Nakamura, Yasuo Terauchi
Journal of Diabetes Investigation
|
March 25, 2015
Present status of clinical deployment of glucokinase activators
Akinobu Nakamura, Yasuo Terauchi
Journal of Diabetes Investigation
|
May 21, 2014
Relationship between urinary sodium excretion and pioglitazone-induced edema
Akinobu Nakamura, Takeshi Osonoi, Yasuo Terauchi
Diabetes, Obesity & Metabolism
|
June 9, 2021
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Akinobu Nakamura, Kazuno Omori, Yasuo Terauchi
Development (Cambridge, England)
|
August 2, 2021
Shedding light on developmental ERK signaling with genetically encoded biosensors
Akinobu Nakamura, Yuhei Goto, Yohei Kondo, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 190) with videos related to
Sort By:
Page
of 19
Endocrine Journal
|
April 14, 2022
Glucokinase as a therapeutic target based on findings from the analysis of mouse models
Akinobu Nakamura
International Journal of Molecular Sciences
|
May 14, 2022
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function
Akinobu Nakamura
Journal of Diabetes Investigation
|
August 28, 2021
Impaired insulin secretion and related factors in East Asian individuals
Akinobu Nakamura, Yasuo Terauchi
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2017
Ratiometric fluorescence imaging of nuclear pH in living cells using Hoechst-tagged fluorescein
Akinobu Nakamura, Shinya Tsukiji
International Journal of Molecular Sciences
|
November 29, 2013
Lessons from mouse models of high-fat diet-induced NAFLD
Akinobu Nakamura, Yasuo Terauchi
Endocrine Journal
|
September 14, 2012
Factors associated with the glucose-lowering effect of vildagliptin identified from the results of the oral glucose tolerance test in Japanese patients with type 2 diabetes
Akinobu Nakamura, Yasuo Terauchi
Journal of Diabetes Investigation
|
March 25, 2015
Present status of clinical deployment of glucokinase activators
Akinobu Nakamura, Yasuo Terauchi
Journal of Diabetes Investigation
|
May 21, 2014
Relationship between urinary sodium excretion and pioglitazone-induced edema
Akinobu Nakamura, Takeshi Osonoi, Yasuo Terauchi
Diabetes, Obesity & Metabolism
|
June 9, 2021
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Akinobu Nakamura, Kazuno Omori, Yasuo Terauchi
Development (Cambridge, England)
|
August 2, 2021
Shedding light on developmental ERK signaling with genetically encoded biosensors
Akinobu Nakamura, Yuhei Goto, Yohei Kondo, et al.
Page
of 19